News from auspex pharmaceuticals A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 07, 2014, 08:00 ET

Auspex Pharmaceuticals Appoints Industry Veterans Lynn Bleil And Scott Greer To Its Board Of Directors

 Auspex Pharmaceuticals, Inc. (Nasdaq: ASPX), a late clinical stage biopharmaceutical company focused on developing and...

Mar 31, 2014, 16:57 ET

Auspex Pharmaceuticals Added To The Russell 2000® Index

Auspex Pharmaceuticals, Inc. (Nasdaq: ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel...

Mar 27, 2014, 16:19 ET

Auspex Pharmaceuticals Reports 2013 Fourth Quarter And Full Year 2013 Financial Results

 Auspex Pharmaceuticals, Inc. (Nasdaq: ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel...

Mar 25, 2014, 16:01 ET

Auspex Announces The Issuance Of Patents On Deuterium-Containing Form Of Pirfenidone (SD-560)

Auspex Pharmaceuticals, Inc. (Nasdaq: ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel...

Mar 24, 2014, 08:00 ET

Auspex To Present at BioCentury's Future Leaders in the Biotech Industry Conference

Auspex Pharmaceuticals, Inc. (Nasdaq: ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel...

Feb 10, 2014, 16:00 ET

Auspex Announces Completion Of Initial Public Offering And Exercise In Full Of Underwriters' Over-Allotment Option

Auspex Pharmaceuticals, Inc. (Nasdaq: ASPX), a biopharmaceutical company focused on developing and commercializing novel medicines for the...

Feb 05, 2014, 00:07 ET

Auspex Announces Pricing Of Initial Public Offering

 Auspex Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing novel medicines for the treatment of...

Jan 08, 2014, 08:00 ET

Auspex Raises $35 Million And Appoints Industry Veteran Gerald Proehl To Its Board of Directors

 Auspex Pharmaceuticals, Inc., a Phase 3 clinical stage biopharmaceutical company focused on developing and commercializing novel medicines for...

Oct 17, 2013, 08:00 ET
Auspex Pharmaceuticals.  (PRNewsFoto/Auspex Pharmaceuticals)

Auspex Appoints Pratik Shah as CEO and Expands Executive Team

 Auspex Pharmaceuticals, Inc., a privately-held clinical stage biopharmaceutical company focused on developing innovative therapeutics for the...

Jul 11, 2013, 11:05 ET
Auspex Pharmaceuticals.  (PRNewsFoto/Auspex Pharmaceuticals)

Auspex Initiates Phase 3 Trial of SD-809 in Huntington's Disease

 Auspex Pharmaceuticals announced today that the first patient has been enrolled in a multi-center Phase 3 pivotal trial of its lead...

Nov 15, 2012, 08:30 ET

Auspex Pharmaceuticals Receives U.S. Patent on Novel JAK Inhibitor SD-900

Auspex Pharmaceuticals, Inc. today announced that it has been granted U.S. Patent No. 8,299,084 covering the company's novel JAK kinase inhibitor...